affimed.com (AFMD) Company Sales Volume
Demand for lymphoma treatment remains stable and independent of macroeconomic conditions, as confirmed by Affimed (AFMD) actual sales. The value of 0.00 determines the current status of the parameter. Revenue growth is driven by partner payments and the success of "engager" antibody tests. To strengthen its position, Affimed is reducing costs, focusing on NK cells and seeking new B2B alliances within the immuno-oncology sector.
Comprehensive metric breakdowns and analytics for Affimed NV (AFMD)
- price and consensus price forecast:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
- business earnings and investment ratios data:
AFMD - Net Profit|Net Profit Forecast Affimed|AFMD - P/E Multiple|Forward P/E Multiple Affimed Therapeutics|AFMD - PEG Multiple|Company Value to Operating Income Before Depreciation Ratio Affimed N.V.|AFMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Affimed|AFMD - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months affimed.com|AFMD - Earnings per share growth in current year|Net earnings per share change forecast for next year Affimed
- company sales and revenue statistics:
Summary company analysis:Affimed
For an investor in Affimed (AFMD), which develops innovative immunotherapy for oncology centers, this indicator serves as a tool to verify actual commercial demand for anti-tumor drugs. By analyzing the company's sales efficiency, we track daily cash inflows from clients, allowing us to distinguish fundamental revenue growth from speculative momentum and assess the sustainability of the business model within the targeted drug segment.
Analysis of competing companies
Revenue and Sales Volume argenx BVBA|Company Revenue BioNTech SE (BNTX)|Abivax SA - Company Sales Volume|Revenue and Sales Volume ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Company Total Revenue|Immunovant Corp - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|GRFS: Revenue and Sales Volume|Company Annual Revenue ADPT (adaptivebiotech.com)|CLDX (Celldex Therapeutics, Inc.) - Revenue and Sales Volume|Aurinia Pharmaceuticals Inc - Company Annual Revenue|Revenue and Sales Volume BCRX|Company Gross Revenue Vera Corp|Company Revenue Dianthus Therapeutics DNTH|PHVS - Company Sales|AbCellera - Revenue and Sales Volume|Company Total Revenue Tourmaline Bio Inc|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|NKTR (Nektar Therapeutics) - Revenue and Sales Volume|Revenue and Sales Volume upstreambio.com|Revenue and Sales Volume ZBIO|IMNM: Company Annual Revenue|Company Revenue Gossamer Corp GOSS|KALV - Company Sales|Septerna Inc - Revenue and Sales Volume|PVLA (pieris.com) - Company Sales Volume|Savara (SVRA) - Company Revenue|Company Annual Revenue RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Revenue and Sales Volume|ATXS: Company Sales Revenue|Revenue and Sales Volume ENGN|Revenue and Sales Volume rapt.com (RAPT)|Company Revenue Aerovate Therapeutics JBIO|Company Sales Revenue ACRS|KYTX - Company Revenue|Tiziana Life Sciences, Ltd. (TLSA) - Company Sales|CABA: Revenue and Sales Volume|ventyxbio.com (VTYX) - Revenue and Sales Volume|Company Sales THTX|AVTX: Company Sales Revenue|Revenue and Sales Volume ELDN|Company Gross Revenue Agenus, Inc|Company Revenue Climb Bio Inc CLYM|ZURA - Company Sales|ATYR - Company Revenue|Adagene (ADAG) - Company Sales|IMA (ikenaoncology.com) - Company Sales|Shattuck Labs (STTK) - Revenue and Sales Volume|Company Revenue Equillium Inc|Company Sales Volume CNTB (Connect Pharma)|Revenue and Sales Volume IMUX|ATRA - Company Total Revenue|Revenue and Sales Volume IFRX (InflaRx)|Revenue and Sales Volume X4 Pharmaceuticals, Inc XFOR|Adicet - Revenue and Sales Volume|Company Annual Revenue CELU|INMB: Revenue and Sales Volume|Company Annual Revenue BRNS (Barinthus Biotherapeutics PLC)|KZR (Kezar Life Sciences, Inc) - Revenue and Sales Volume|SAB Biotherapeutics Inc (SABS) - Company Gross Revenue|Company Revenue Akari Therapeutics (AKTX)|Company Sales enlivex.com ENLV|Revenue and Sales Volume QTTB (Q32 Bio)|GeoVax Labs (GOVX) - Company Total Revenue|Edesa - Revenue and Sales Volume|IBIO (iBio Corporation) - Company Sales Volume|CARM: Revenue and Sales Volume|xtlbio.com (XTLB) - Revenue and Sales Volume|BOLT (Bolt Biotherapeutics Inc.) - Revenue and Sales Volume|HCW Biologics Inc - Company Annual Revenue|Company Revenue Aptevo Therapeutics (APVO)|Company Sales aimimmuno.com AIM|Revenue and Sales Volume ADTX (Aditxt, Inc.)|GRI: Company Sales Volume|XRTX - Company Revenue|Company Annual Revenue HIND|REVB: Revenue and Sales Volume|Indaptus Corp - Company Sales Revenue|SCNI (Scinai Immunotherapeutics) - Revenue and Sales Volume|Revenue and Sales Volume CalciMedica Corp|Company Revenue Allakos Inc. (ALLK)|HOOK (hookipapharma.com) - Company Sales Revenue|Company Revenue IGM Biosciences IGMS|ITOS - Company Sales|Ocean Biomedical, Inc. - Revenue and Sales Volume|TCBP - Revenue and Sales Volume|THRD (Third Harmonic Bio, Inc.) - Company Sales
